-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Apogee Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2023 to 2024.
- Apogee Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $4.19 M, a 229% increase year-over-year.
- Apogee Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.1 M, a 185% increase from 2022.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)